Drug shortage registry under discussion.
نویسنده
چکیده
ciation is negotiating with drug manufacturers, hospital pharmacists and the Canadian Medical Association to create a national reporting system that would track drug shortages. “We still have a long way to go, but the discussions have started,” says Jeff Morrison, director of government relations and public affairs for the Canadian Pharmacists Association. Recent shortages of cancer drugs such as carboplatin, cytarabine, dacarbazine and vinorelbine, as well as periodic shortages of drugs ranging from some common antibiotics to anesthetics and antinausea medications have prompted physicians, pharmacists and other health care professionals to call for a national registry or portal modelled on one hosted by the American Society of Health System Pharmacists. In the United States, a physician or pharmacist encountering a drug shortage can inform the American Society of Health System Pharmacists, which then contacts manufacturers to confirm the shortage and obtain an estimated date when the drug might be available again. “It works great — it’s highly valued by both doctors and pharmacists in the States, and we have nothing like it in Canada,” says Morrison. “That’s what we’re trying to create.” A central registry that lists available alternatives to drugs in short supply would also save pharmacists and health care professionals time, says Myrella Roy, executive director of the Canadian Society of Hospital Pharmacists. The pharmacists and interested stakeholders, who will meet again in June, have spoken to Health Minister Leona Aglukkaq and secured her support, he says. But they have not yet determined a funding source for the registry. “Minister Aglukkaq recently tasked Health Canada with exploring options for improved management of drug shortages, and has written to industry to ensure a collaborative approach on this important issue,” Health Canada writes in an email. Currently, although manufacturers may contact Health Canada about shortages, they are not required to do so — something some physicians feel needs to change. Advance warning of pending shortages of carboplatin would have helped the Juravinski Cancer Centre in Hamilton, Ontario, which in May found itself without any carboplatin to treat patients with breast and lung cancer, says Dr. Peter Ellis, an oncologist at the centre. “We got three days’ notice that there was no drug supply,” Ellis says. “We were told there was a manufacturing issue and there wasn’t any additional information forthcoming. There are varying potential explanations for that, but one would have to assume the manufacturer had more warning of this than we did.” Although Ellis’ patients had their treatments delayed or modified for only about a week, he is worried that if these shortages persist they could affect the quality of patient care. Some form of federal government News CMAJ
منابع مشابه
Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy
BACKGROUND The U.S Congress initiated sanctions against Iran after the 1979 U.S. Embassy hostage crisis in Tehran, and since then the scope of multilateral sanctions imposed by the United States, the European Union, and the United Nations Security Council have progressively expanded throughout the intervening years. Though primarily targeted at Iran's nuclear proliferation activities, sanctions...
متن کاملOptimal New Energy Vehicle Production Strategy Considering Subsidy and Shortage Cost ¬リニ
In this paper, we present an analytical model to investigate how the optimal production strategy of new energy vehicles (NEVs) is influenced by subsidy, market fluctuation, and loss aversion. We find that a loss averse decision maker may produce more production quantity than the optimal quantity in risk neutrality under the certain conditions. We demonstrate that the expected utility is substan...
متن کاملDrug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program
BACKGROUND For patients on antiretroviral therapy (ART), treatment interruptions can impact patient outcomes and result in the accumulation of drug resistance mutations leading to virologic failure. There are minimal published data on the impact of an ART stock shortage on development of drug resistance mutations (DRMs). In this report, we evaluate data from patients enrolled in the Government ...
متن کاملDeveloping a Method for Reporting Patient Harm Due to Antimicrobial Shortages
INTRODUCTION The number of drug shortages in the United States has increased in recent years. While some literature exists on factors that contribute to antimicrobial shortages, the need remains to accurately gage the level of patient harm incurred as a result of realized antimicrobial shortages. Furthermore, current methods of reporting adverse drug events are known to under-report instances o...
متن کاملThe drugs stop here: a public health framework to address the drug shortage crisis.
Drug shortages are emerging as a major public health threat. Grave concern has been expressed by the medical community and government officials, and the crisis has been highlighted in recent media stories. Nevertheless, little has been written to date in the legal literature about the drug shortage crisis, and this timely article begins to fill this gap. It provides a thorough analysis of the o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
دوره 183 10 شماره
صفحات -
تاریخ انتشار 2011